Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$337M |
| 2 |
Pfizer
PFE
|
+$315M |
| 3 |
Chevron
CVX
|
+$266M |
| 4 |
Procter & Gamble
PG
|
+$236M |
| 5 |
JPMorgan Chase
JPM
|
+$221M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Healthcare | 13.11% |
| 3 | Technology | 12.26% |
| 4 | Consumer Discretionary | 9.3% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
PepsiCo
PEP
$196B
| $100M | 0.36% |
+1,226,200
| New | +$100M |
|
52
Zoetis
ZTS
$32.1B
| $99M | 0.35% |
+3,206,272
| New | +$104M |
|
53
Ameriprise Financial
AMP
$49.1B
| $98.2M | 0.35% |
+1,214,386
| New | +$94.4M |
|
54
TSMC
TSM
$2.17T
| $97.8M | 0.35% |
+5,339,162
| New | +$98.3M |
|
55
CF Industries
CF
$19.6B
| $97.2M | 0.35% |
+2,834,990
| New | +$106M |
|
56
Archer Daniels Midland
ADM
$38.7B
| $92.1M | 0.33% |
+2,716,028
| New | +$90.6M |
|
57
Biogen
BIIB
$32B
| $91.8M | 0.33% |
+426,608
| New | +$91.2M |
|
58
Everest Group
EG
$14.2B
| $91.3M | 0.32% |
+712,154
| New | +$92.1M |
|
59
Macy's
M
$6B
| $90.9M | 0.32% |
+1,893,055
| New | +$87.9M |
|
60
Unum
UNM
$13.9B
| $88M | 0.31% |
+2,997,815
| New | +$83.5M |
|
61
Assurant
AIZ
$14B
| $87.5M | 0.31% |
+1,719,482
| New | +$83.4M |
|
62
Fidelity National Information Services
FIS
$21.3B
| $87.2M | 0.31% |
+2,035,600
| New | +$87M |
|
63
Marvell Technology
MRVL
$213B
| $86.7M | 0.31% |
+7,406,093
| New | +$80.3M |
|
|
ACAS
64
DELISTED
American Capital Ltd
ACAS
| $85.9M | 0.3% |
+6,778,817
| New | +$93.4M |
|
65
McKesson
MCK
$100B
| $84.5M | 0.3% |
+737,940
| New | +$82.1M |
|
66
SLM Corp
SLM
$4.97B
| $82.5M | 0.29% |
+10,097,319
| New | +$78.8M |
|
67
DTE Energy
DTE
$28.1B
| $82.3M | 0.29% |
+1,442,793
| New | +$85M |
|
|
ESRX
68
DELISTED
Express Scripts Holding Company
ESRX
| $81.9M | 0.29% |
+1,327,173
| New | +$79.9M |
|
69
Best Buy
BBY
$18.1B
| $81M | 0.29% |
+2,962,985
| New | +$76.4M |
|
|
BRCD
70
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $80.7M | 0.29% |
+14,017,449
| New | +$78.3M |
|
71
Humana
HUM
$45.5B
| $79.1M | 0.28% |
+937,034
| New | +$74M |
|
|
CA
72
DELISTED
CA, Inc.
CA
| $78.2M | 0.28% |
+2,731,900
| New | +$73.2M |
|
73
Comcast
CMCSA
$95.3B
| $77.9M | 0.28% |
+3,719,746
| New | +$76.8M |
|
74
Stryker
SYK
$126B
| $76.5M | 0.27% |
+1,182,389
| New | +$78.5M |
|
|
RTN
75
DELISTED
Raytheon Company
RTN
| $76.1M | 0.27% |
+1,150,253
| New | +$72.7M |
|
Similar funds
Cliff Asness's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Cliff Asness, which disclosed 2,329 positions worth $28.2B. Its ten largest holdings account for 8.5% of the portfolio.
Its largest position is ExxonMobil: 3,744,346 shares worth $338M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, followed by Healthcare and Technology.
- Cliff Asness's largest Q2 2013 buy was ExxonMobil: 3,744,346 shares worth $338M.
- Cliff Asness's ten largest holdings make up 8.5% of its $28.2B portfolio in Q2 2013.
- Cliff Asness disclosed 2,329 positions in Q2 2013, its first 13F filing on record.
Based on AQR Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.